Investigative Site 19 — Dallas, Texas

Investigative Site 19 is a clinical research site located in Dallas, Texas, United States 75390.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Investigative Site 19 has participated in 1 clinical trials.

Therapeutic areas: Paroxysmal Nocturnal Hemoglobinuria (PNH).

Sponsors: Ra Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigative Site 19?

Investigative Site 19 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigative Site 19 conducted?

Investigative Site 19 has 1 clinical trials on record. Their work covers Paroxysmal Nocturnal Hemoglobinuria (PNH).

Is Investigative Site 19 accredited by Crixeo Health?

Investigative Site 19 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigative Site 19?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.